ArticleMaterials today. Bio2022

Enhanced anti-glioma efficacy of doxorubicin with BRD4 PROTAC degrader using targeted nanoparticles.

Yihong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.